Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancement of Post-stroke Neural Plasticity With Atomoxetine: a Pilot Study

NCT02788357 is registered in ClinicalTrials.gov with Lumy Sawaki as lead sponsor.

NCT NCT02788357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02788357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancement of Post-stroke Neural Plasticity With Atomoxetine: a Pilot Study
Lead sponsor
Lumy Sawaki
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2006
Completion date
December 31, 2014
Enrollment
12 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atomoxetine hydrochloride, placebos